Sign in
4

Changes in Ownership

ADC Therapeutics SA Filed Acc 0001628280-26-009283

Chief Accounting Officer acquired 62,900 shares (grant or award)

  • Chief Accounting Officer gave up 5,433 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kallebo Lisa Michelle Chief Accounting Officer 2026-02-13 Grant or award +62,900 $3.99 $250,971 133,657 D
Kallebo Lisa Michelle Chief Accounting Officer 2026-02-13 Shares withheld for taxes −5,433 $3.99 $21,678 128,224 D
Loading xslF345X05/wk-form4_1771454641.xml…